Recurrent Stroke Due to a Novel Voltage Sensor Mutation in Ca v 2.1 Responds to Verapamil-Reference-Cited by-同舟云学术

Recurrent Stroke Due to a Novel Voltage Sensor Mutation in Ca v 2.1 Responds to Verapamil

Published:2011-02 Issue:2 Volume:42 Page:
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Knierim Ellen¹,Leisle Lilia¹,Wagner Christiane¹,Weschke Bernhard¹,Lucke Barbara¹,Bohner Georg¹,Dreier Jens P.¹,Schuelke Markus¹

Affiliation:

1. From the Department of Neuropediatrics (E.K., C.W., B.W., B.L., M.S.), the NeuroCure Clinical Research Center (E.K., B.L., M.S.), the Department of Neuroradiology (G.B.), and the Center for Stroke Research (J.P.D.), Charité Universitätsmedizin Berlin, Berlin, Germany; and the Leibniz-Institute for Molecular Pharmacology and Max-Delbrueck-Center for Molecular Medicine (L.L.), Berlin, Germany.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference17 articles.

1. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy

2. Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation

3. Management of sporadic and familial hemiplegic migraine

4. CaV2.1 channelopathies

5. MutationTaster evaluates disease-causing potential of sequence alterations

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroke and Stroke-Like Episodes: Recurrent Manifestations in GLUT1 Deficiency Syndrome;Pediatric Neurology;2024-08

2. Loss of Epitranscriptomic Modification N6-Methyladenosine (m6A) Reader YTHDF1 Exacerbates Ischemic Brain Injury in a Sexually Dimorphic Manner;Translational Stroke Research;2024-06-13

3. Familial hemiplegic migraine;Handbook of Clinical Neurology;2024

4. Concomitant Calcium Channelopathies Involving CACNA1A and CACNA1F: A Case Report and Review of the Literature;Genes;2023-02-03

5. Stroke and Stroke-Like Episodes as a New Clinical Manifestation in Glut1 Deficiency Syndrome;2023